Breakthrough Therapy for IgG4-Related Disease Reduces Flares

Inebilizumab offers new hope for managing this chronic autoimmune condition.

Nov 21, 2024

∙ Paid

A modern, professional illustration of a healthcare setting focused on autoimmune disease treatment. The scene features a diverse group of healthcare professionals and patients in a clinical environment. Highlight a clean and innovative atmosphere with a focus on safety and care, including subtle visual elements like a vial labeled 'Inebilizumab' on a medical counter. The design should emphasize hope and progress in medical treatment, using a light color palette with touches of green and blue to convey calmness and trust.

Topline

A phase 3 trial reveals that inebilizumab dramatically reduces flares and boosts remission rates in IgG4-related disease, offering a safer, steroid-sparing treatment option.

What is IgG4-Related Disease?

IgG4-related disease (IgG4-RD) is a chronic autoimmune condition marked by fibro-inflammatory lesions in multiple organs, often mimicking cancer. …

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.